About GobyPeptides
GobyPeptides exists to make the peptide review cycle readable, clinically grounded, and useful without drifting into gray-market fantasy.
Providing authoritative, physician-aware peptide education backed by real clinical research and regulatory context. Not speculation. Not anonymous sourcing. Science first.
GobyPeptides is designed as the educational front door for readers who want to understand the peptide landscape before they decide what to follow more closely. GobyMeds is the physician-led telehealth company behind that broader care conversation. Some treatments are already available now through licensed care, while others are still waiting on FDA review and compounding decisions. In both cases, the goal is a legitimate care path with clinician review and pharmacy oversight, not a shortcut around medical judgment.
Research-backed
Every page starts from the in-repo source research and keeps a careful editorial voice around evidence limits.
Medical-grade lens
The site treats access, sourcing, and physician oversight as part of the safety story rather than afterthoughts.
Built for legitimacy
The purpose is to help readers navigate lawful peptide access when it exists, not to glamorize the gray market.
When patients lose legitimate access, demand does not disappear. It often moves underground. GobyPeptides exists because the safer future is one where readers understand what the FDA is reviewing, what reclassification would and would not mean, and how physician-led care differs from speculative self-experimentation.
Our approach
Use the quiz if you want a cleaner starting point.
The quiz is built for readers who know the broad goal they care about but do not yet know which peptides are worth following first.